Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: An assessment of currently available triazoles

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

The use of voriconazole, a trifluorinated antifungal, has been associated with the development of fluoride excess and periostitis/ exostoses. We evaluated a cohort of patients on long-term triazole therapy and found that other fluorinated triazoles (fluconazole and posaconazole) conferred no risk for the development of hyperfluorosis and its complications in our cohort.

Original languageEnglish (US)
Pages (from-to)563-564
Number of pages2
JournalAntimicrobial Agents and Chemotherapy
Volume56
Issue number1
DOIs
StatePublished - Jan 2012

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: An assessment of currently available triazoles'. Together they form a unique fingerprint.

Cite this